Neuropace Inc reports results for the quarter ended in December - Earnings Summary

NeuroPace

02/03/2023 22:13

* Neuropace Inc  NPCE.OQ  reported a quarterly adjusted loss
of 45
cents​​ per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss
of 49 cents per share.
    * Revenue rose 16.3% to $12.79 million from a year ago;
analysts
expected $12.40 million. 
    * Neuropace Inc's reported EPS for the quarter was a loss
of 45
cents​.
    * The mean earnings estimate of analysts had risen by
about 1% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Neuropace Inc shares had risen by 217.4% this quarter.
    * The company reported a quarterly loss of $11.15 million.
    * Wall Street's median 12-month price target for Neuropace
Inc is
$6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data March 2
at 10:13 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.49          -0.45          Beat
 Sep. 30 2022      -0.53          -0.48          Beat
 Jun. 30 2022      -0.44          -0.52          Missed
 Mar. 31 2022      -0.44          -0.47          Missed